The size of the Asia Pacific Protein Chip Market was worth USD 0.47 Billion in 2021 and estimated to be growing at a CAGR of 18.6%, to reach USD 1.11 billion by 2026.
Protein Chip is used to track the activity of proteins. It is used to monitor the expression of the protein and helps in determining the function of large number of proteins in a single experiment. The surface of the protein chip is made of nitrocellulose membrane, microtitre plate, glass slide, and bead. The surface helps in tracking all the activities of proteins.
The major factors driving the growth of the market are increasing practice for advanced technology in diagnostic test rising rate of incidences of cancer and. The rise in the awareness about personalized medicines is also contributing to the growth of the market. However, complex technicalities associated with the protein chips and the lack of healthcare coverage is the major factor that is hampering the growth of the Protein Chip market.
The market for Protein Chip is broadly categorized into technology and application. By technology the market is classified into analytical microarrays, functional protein microarrays and reverse phase protein microarrays. Functional protein microarray segment accounts for a major share in the market due to its widespread application in advanced diagnostics. By application the market is segmented into diagnostics, proteomics, protein functional analysis and antibody characterization. Proteomics is the largest revenue generating segment.
On the basis of geography, the market is analysed under various regions China, India, Japan, Australia and South Korea. Asia Pacific is expected to grow at a significant rate during the forecast period owing to the financial improvement of some the Asian countries such as India, China and Malaysia. Moreover, most of the drug development companies outsourced their clinical trial drug development studies in Asian countries owing to its large pool of population.
Some of the market players operating in this industry segment include SEQUENOM, Inc., Sigma Aldrich Corporation, Affymetrix, Inc. , EMD Millipore, Illumina, Inc., Life Technologies Corporation, and Agilent Technologies.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Technology
5.1.1 Introduction
5.1.2 Analytical microarrays
5.1.3 Functional protein microarrays
5.1.4 Reverse phase protein microarray
5.1.5 Y-o-Y Growth Analysis, By technology
5.1.6 Market Attractiveness Analysis, By technology
5.1.7 Market Share Analysis, By technology
5.2 Application
5.2.1 Introduction
5.2.2 Diagnostics
5.2.3 Proteomics
5.2.4 Protein functional analysis
5.2.5 Antibody characterization
5.2.6 Y-o-Y Growth Analysis, By application
5.2.7 Market Attractiveness Analysis, By application
5.2.8 Market Share Analysis, By application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By technology
6.1.3.3 By application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By technology
6.1.4.3 By application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By technology
6.1.5.3 By application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Agilent Technologies
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Affymetrix Inc.
8.3 Sigma Aldrich Corporation
8.4 SEQUENOM
8.5 Life Technologies Corporation
8.6 IIIumina Inc.
8.7 EMD Milipore
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Apr 2021
